Copan Colibrí™ Receives Third FDA Clearance, Further Expanding Automated ID/AST Workup Capabilities
![](https://www.copanusa.com/wp-content/uploads/2021/06/Overview_22-1024x341.jpg)
![](https://www.copanusa.com/wp-content/uploads/2021/06/Overview_22-640x213.jpg)
Colibrí™, COPAN’s Automated Specimen Workup Instrument, Receives FDA 510(k) Clearance for use with bioMérieux VITEK® 2 Antimicrobial Susceptibility Testing (AST) System
October 10, 2022
![](https://www.copanusa.com/wp-content/uploads/2023/07/Overview_4-640x213.jpg)
![](https://www.copanusa.com/wp-content/uploads/2021/06/Overview_21-640x213.jpg)
COPAN Diagnostics Announces Another Giant Step in the Evolution of Artificial Intelligence in Clinical Microbiology
January 19, 2022
![](https://www.copanusa.com/wp-content/uploads/2022/01/phenomatrix-tag-970x536-1-640x354.jpg)
Colibri™ Automated Specimen Workup Instrument by COPAN Receives FDA 510(k) Clearance for Use with MALDI-TOF Mass Spectrometry Analyzers
January 5, 2022